Fabrizio Greco, Vice President and Chief Executive Officer of AbbVie Italia since 1 January 2013, has been appointed President of the IAPG - Italian American Pharmaceutical Group, which brings together Italian pharmaceutical companies with American capital and is also one of the components of Farmindustria.
In the past, Fabrizio Greco held the position of Chief Executive Officer of Abbott in Italy and General Manager PPD (Product Pharmaceutical Division), after having been Chief Executive Officer of Abbott Vascular Italy. Previously he had assumed positions of increasing responsibility in Guidant until he became General Manager of the subsidiary in Portugal. Graduated in Engineering at the University of Genoa, after a Masters in Business Administration at Bocconi, he began his career at Eli Lilly Italia.
“I would like to thank you for the trust placed in me – commented Fabrizio Greco – and I would like to recall the important and growing contribution made to the country by the 16 companies that belong to IAPG in terms of innovation, investments, exports, employment and research. In pharmaceuticals, Italy is in fact the leading country in Europe in attracting more American investments: more than 2 billion euros in the last 5 years, of which 57% in Research & Development. The companies gathered in the IAPG represent a significant share of the pharmaceutical sector in our country: in 2016, according to data processed by Farmindustria, they generated 7,3 billion euros in turnover, equal to a quarter of the entire sector and 1,8 billion euros of exports”.
"To maintain and improve these results - concluded Fabrizio Greco - it will be essential to continue our dialogue with the various stakeholders, in order to contribute to the definition of a new pharmaceutical governance which, starting from adequate financing for the demand for health, favors the research and innovation and allows rapid and homogeneous access to treatment, for the benefit of patients and the sustainability of the health system".
